Assistant Professor in the Department of Nutrition
Dr. Qi’s major research interests include:
- Genetic/nutrition Epidemiology of type 2 diabetes, cardiovascular complications, and obesity
- Gene-environment interactions in relation to obesity, type 2 diabetes and cardiovascular disease
- Lifestyle/diet intervention in prevention of obesity and metabolic disorders
- Application of metabolomics and epigenetics in epidemiology research
Dr. Qi’s research has focused on the genetic, nutrition, biochemical risk factors and gene-environment interactions in relation to obesity, type 2 diabetes and the cardiovascular complications in diabetic patients. Dr. Qi is the Principal Investigator of NIH R01 grant ‘Obesity Genes, Energy Regulation in Response to Weight-Loss Diets’ (NIDDK), a study in large cohorts (the NHS and HPFS) and randomized intervention trials (the Pounds Lost trial and DIRECT trial); he is the Principal Investigator of NIH R01 grant on the genome-wide association study of coronary heart disease among diabetic patients in the NHS and HPFS (NHLBI); he is the Principal Investigator of the American Heart Association Scientist Development Grant on the biochemical and genetic predictors for cardiovascular disease in diabetes; he is Co-Principal Investigator of European Foundation for the Study of Diabetes (EFSD) funded lifestyle intervention trial on prevention of metabolic risk in women with history of gestational diabetes (GDM). As Principal Investigator, he is also leading a metabolomic study in two diet intervention trials funded by U.S. – Israel Binational Science Foundation.
Dr. Qi serves as Editor-in-Chief for World Journal of Diabetes, Associate Editor for BMC Medical Genetics, and editorial board member for the Journal of Nutrition, the International Journal of Molecular Epidemiology and Genetics, and Frontiers in Nutrigenomics. Dr. Qi is a fellow of American Heart Association (FAHA) and American College of Nutrition (FACN).
World Journal of Diabetes: http://www.wjgnet.com/1948-9358/edboard.htm
‘Sugar-Sweetened Beverages and Genetic Risk of Obesity’
‘Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes’